Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VRTX · against 596 other Healthcare companies listed in US-listed
Ranked #199 of 597 · scores higher than 67% of peers · safety percentile 72
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)41 peers with a safety percentile of 70–79, including VRTX · Click a bar to see the companies
Mainly thanks to its debt / equity and beta, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | VRTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 523 reported | 0.10× | 0.23× | 63% | 33% | |
| BetaLower is better · 556 reported | 0.32 | 0.95 | 84% | 33% | |
| Current ratioHigher is better · 600 reported | 3.19× | 3.91× | 43% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 5.6B USD | 100 | 53 | |
| 1 | 6.6B USD | 100 | 45 | |
| 3 | 186M USD | 100 | 52 | |
| 4 | 1.5B USD | 100 | 44 | |
| 5 | 1.2B USD | 100 | 40 | |
| 195 | 264M USD | 73 | 30 | |
| 196 | 2.3B USD | 73 | 27 | |
| 197 | 49.1B USD | 73 | 69 | |
| 198 | 609M USD | 72 | 91 | |
| 199 | 134.5B USD | 72 | 70 | |
| 200 | 8.9B USD | 72 | 51 | |
| 201 | 13.7B USD | 72 | 45 | |
| 202 | 4.0B USD | 72 | 72 | |
| 203 | 5.8B USD | 71 | 68 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score